For medical bonding, potting and sealing applications, Henkel Corporation has introduced a rapid curing, highly flexible visible light cure adhesive formulation, Loctite® 3974™.  Curing tack-free in seconds, this new adhesive permanently bonds materials with differing coefficients of thermal expansion (CTE) and easily accommodates substrate expansion and contraction.

Loctite® 3974™ Light Cure Adhesive is a low modulus, single-component acrylic adhesive that cures rapidly on exposure to UV or visible light.  This adhesive can be used on glass, thermoplastic and metal assemblies that must withstand extreme thermal cycling and environmental exposure.  Loctite® 3974™ Light Cure Adhesive has a Shore hardness of A70 and an elongation of 100 percent, making it ideally suited for highly flexible components.

Loctite® 3974™ Light Cure Adhesive is ISO-10993 biologically tested, making it suitable for the assembly of disposable medical devices.  This adhesive fluoresces under black light for easy quality control inspection and is available in a variety of package sizes to accommodate manual to fully automated dispensing.

For more information on Loctite® 3974™, call 1-888-LOCTITE, email marketing@loctite.com, or visit the company’s medical website at www.loctite.com.

For more than 130 years, Henkel has been a leader with brands and technologies that make people's lives easier, better, and more beautiful. Henkel operates in three business areas -- Home Care, Personal Care, and Adhesives Technologies -- and ranks among the Fortune Global 500 companies. In fiscal 2007, Henkel generated sales of $19.218 billion and operating profit of $1.975 billion. Our 53,000 employees worldwide are dedicated to fulfilling our corporate claim, "A Brand like a Friend," and ensuring that people in more than 125 countries can trust in brands and technologies from Henkel.